Oncimmune Holdings Reports Autoantibody Profiling Program Agreement Signed with ImmunoINSIGHTS, World-Leading BioPharm Company
Oncimmune CEO dam M Hill said: "We are pleased to announce this partnership between our ImmunoINSIGHTS business and another world-leading biopharmaceutical company."